Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-10-27Clinical Trial Update: Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement [Phase 4]
A Phase 4 trial evaluating intraoperative injections for postoperative pain control during total hip replacement has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: Safety and Effectiveness Study of the Reflection Ceramic Acetabular System [NA]
A completed clinical trial evaluating safety and effectiveness of the Reflection Ceramic Acetabular System for osteoarthritis with results p…
-
FDA approval · 2022-10-06FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s Naproxen and Esomeprazole Magnesium as an Original Application (ANDA213699), providing a generic versi…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Steroids in Total Knee Arthroplasty [Phase 4]
Phase 4 trial assessing steroids for postoperative pain and inflammation after total knee arthroplasty was terminated; results posted in 202…
-
FDA approval · 2022-09-28FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for ARTHRITIS PAIN RELIEVER (diclofenac sodium) by Publix Super Markets Inc. This action approves ch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-09-15FDA Approved: CELECOXIB — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved a supplemental application for a generic celecoxib product from Westminster Pharmaceuticals, expanding access under ANDA210…
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Platelet Rich Plasma (PRP) in Total Knee Replacement [Phase 4]
A Phase 4 clinical trial evaluating platelet rich plasma (PRP) in total knee replacement has been completed.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: EVALUATION OF AN INNOVATIVE TREATMENT FOR RADIOCARPAL OSTEOARTHRITIS USING INTRA-ARTICULAR INJECTION OF A MIXTURE OF AUTOLOGOUS MICROFAT AND AUTOLOGOUS PLATELET-RICH PLASMA [Phase 1, Phase 2]
A clinical trial evaluating intra-articular injection of autologous microfat combined with autologous platelet-rich plasma for radiocarpal o…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis [Phase 4]
Phase 4 trial comparing platelet-rich plasma to hyaluronic acid for shoulder osteoarthritis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating autologous adipose tissue-derived ADSCs for treatment of knee osteoarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients [Phase 2]
Phase 2 trial comparing ATB-346 to placebo in osteoarthritis patients completed; efficacy and safety data reported.
-
FDA approval · 2022-07-18FDA Approved: FENOPRON TM — Original Application (Galt Pharmaceuticals, LLC)
FDA approved Fenoprofen calcium as a generic tablet under an original ANDA submitted by Galt Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis [Phase 2]
Phase 2 study of LY3016859 in osteoarthritis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Treatment of Osteoarthrosis of the Knee With Platelet Rich Plasma, Comparative Study With Hyaluronic Acid [Phase 3]
Phase 3 trial comparing platelet-rich plasma to hyaluronic acid for treatment of knee osteoarthritis has completed.
-
FDA approval · 2022-06-07FDA Approved: NAPROXEN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber's naproxen generic original application for Naproxen. This generic NSAID is approved for relief of pain and inflammation…
-
FDA approval · 2022-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Apotex Corp.)
FDA approved Apotex Corp's original application for diclofenac sodium tablets, a generic NSAID. This approval enables Apotex to market a gen…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty [Phase 3]
Phase 3 trial comparing antimicrobial barrier dressing to closed-incision negative pressure therapy in obese patients undergoing primary tot…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Long-Term Effectiveness of Walking Training in Patients With Knee Osteoarthritis [NA]
Clinical trial update on long-term walking training effectiveness in knee osteoarthritis; study status terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee [Phase 2]
Phase 2 proof-of-concept study assessing a single intraarticular dose of GZ389988 versus placebo for knee osteoarthritis.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain [Phase 3]
Phase 3 study comparing intra-articular CNTX-4975 (capsaicin) to placebo in knee osteoarthritis shows completed results with posted results.
-
FDA approval · 2022-03-22FDA Approved: IBUPROFEN — Supplemental Application (Aurohealth LLC)
The FDA approved a supplemental application for ibuprofen filed by Aurohealth LLC, authorizing the generic ibuprofen product.
-
FDA approval · 2022-03-18FDA Approved: BROMFENAC — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for bromfenac from Aurobindo Pharma Limited, enabling a generic bromfenac product to enter the market.…
-
FDA approval · 2022-03-11FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application for naproxen sodium granules from Granules India Ltd, resulting in an approved supplemental request …
-
FDA approval · 2022-03-09FDA Approved: CELECOXIB — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Celecoxib from Micro Labs Limited under an ANDA.